Express Scripts Holding Co (ESRX.OQ)

ESRX.OQ on NASDAQ Stock Exchange Global Select Market

74.04USD
16 Sep 2014
Price Change (% chg)

$0.65 (+0.89%)
Prev Close
$73.39
Open
$73.54
Day's High
$74.26
Day's Low
$73.35
Volume
1,038,397
Avg. Vol
1,402,025
52-wk High
$79.37
52-wk Low
$59.20

ESRX.OQ

Chart for ESRX.OQ

About

Express Scripts Holding Company provides healthcare management and administration services on behalf of its clients, which include health maintenance organizations (HMOs), health insurers, third-party administrators, employers, union-sponsored benefit plans, workers compensation plans, and government health programs. The Company... (more)

Overall

Beta: 1.15
Market Cap (Mil.): $54,965.75
Shares Outstanding (Mil.): 745.45
Dividend: --
Yield (%): --

Financials

  ESRX.OQ Industry Sector
P/E (TTM): 32.45 18.28 34.18
EPS (TTM): 2.27 -- --
ROI: 4.43 9.57 49.76
ROE: 8.12 10.98 58.09
Search Stocks

Novo Nordisk aims for 2016 Tresiba launch in U.S

COPENHAGEN - Novo Nordisk <NOVOb.CO said on Thursday it could launch its new long-acting insulin Tresiba, a crucial future growth driver for the Danish company, at the start of 2016 in the United States.

07 Aug 2014

UPDATE 2-Novo Nordisk aims for 2016 Tresiba launch in U.S.

* Shares up 1.5 pct (Adds comments from CEO, analysts, share price)

07 Aug 2014

UPDATE 1-GSK gets a lift as Express Scripts reinstates lung drug Advair

* Move may boost use but prices still seen under pressure

04 Aug 2014

GSK gets a lift as Express Scripts reinstates lung drug Advair

LONDON - GlaxoSmithKline (GSK) received a boost on Monday from a decision by Express Scripts, the largest U.S. pharmacy benefit manager, to reinstate its top-selling lung drug Advair as an approved drug in 2015.

04 Aug 2014

UPDATE 2-Express Scripts drops Amgen anemia drugs from formulary

Aug 1 - Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, said on Friday it will remove an additional 25 products from its list of preferred drugs in 2015, including anemia drugs Epogen and Aranesp, sold by Amgen Inc.

01 Aug 2014

Express Scripts drops Amgen anemia drugs from formulary

- Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, on Friday said it will remove 25 products from its 2015 list of preferred drugs, including anemia treatments Epogen and Aranesp, both sold by Amgen Inc.

01 Aug 2014

Express Scripts excludes Amgen drugs from 2015 formulary

Aug 1 - Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, on Friday said it will not include anemia drugs Epogen and Aranesp, both sold by Amgen Inc, on its 2015 list of preferred medications.

01 Aug 2014

Express Scripts narrows full year forecast

July 29 - Express Scripts Holding Co, the largest pharmacy benefits manager in North America, posted a weaker profit and narrowed its full year forecast.

29 Jul 2014

Fitch Rates Express Scripts' Proposed Bond Offering 'BBB'; Outlook Stable

(The following statement was released by the rating agency) CHICAGO, June 02 (Fitch) Fitch Ratings has assigned a 'BBB' rating to the proposed senior unsecured bond issuance by Express Scripts Holding Company (NYSE:ESRX). Proceeds from the issuance are expected to be used for the redemption of ESRX's $900 million and $1.25 billion of unsecured bonds due November 2014 and November 2016, respectively, and for general corporate purposes (including some share repurchase). Fitch currently rates

02 Jun 2014

DIARY-U.S. MEETINGS/WEEK AHEAD

THOMSON REUTERS, May 06,2014 - Corporate Meetings for US companies for Week ahead. S&P 500 Earnings - Weekly S&P 500 Earnings - Day Ahead Non S&P 500 - Weekly Non S&P 500 - Day Ahead ConferenceCall/Webcast - Weekly ConferenceCall/Webcast - Day S&P 500 Earnings - Monthly Meetings - Day Ahead Economic Indicators Dividends Daily earnings hits & misses Federal Rese

06 May 2014

Competitors

  Price Change
UnitedHealth Group Inc. (UNH.N) $87.16 +1.13
Aetna Inc (AET.N) $83.35 +1.23
CIGNA Corporation (CI.N) $93.24 +1.72

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Wright Reports
$75.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks